An intravenous cytotoxic reconstitution service has proved extremely popular with both medical and nursing staff. Since the pharmacy has taken over the responsibility for presenting these medicines in a readily usable form, many potential hazards to inexperienced medical staff have been eliminated, and much time and money have been saved. The pharmacists are in an excellent position to offer advice on many aspects of cytotoxic treatment and are well equipped to spot prescription errors. They are often asked to supply information concerning rates and methods of
BRITISH MEDICAL JOURNAL VOLUME 286 1 polio has not been controlled by regular age-specific immunisation through fixed centres, even in towns with over 60% coverage with three doses. Control was achieved in this campaign as a result of the wild polioviruses in circulation being replaced by the widespread pulse of vaccine viruses.5 Pulse immunisation will increase the coverage rate as well as the seroconversion rate, presumably owing to the circulation of vaccine viruses.4 Thus some children who were missed in the pulse campaign may also become immunised. As a result the circulation of wild polioviruses would be interrupted and the incidence of poliomyelitis in the community would fall. 4 This study shows that polio can be controlled in small geographical units. As more resources become available the area covered can be increased until the whole nation achieves control over polio.
Introduction
The past 20 years has seen an explosion in the introduction of effective cytotoxic agents for treating malignant disease (fig 1) . Not only has the number of agents increased, so has the frequency with which they are used.
Until relatively recently chemotherapy tended to be used only in specialised units on small numbers of patients with rare tumours. With the growth of chemotherapy as an adjuvant to surgery and radiotherapy, however, and with the advent of multicentre clinical trials in common malignancies, these drugs are now prescribed much more widely. This increased use may produce an unduly heavy burden on medical and pharmaceutical resources. It has therefore become necessary to establish facilities to prepare and administer these drugs efficiently, safely, and accurately. Prescriptions for intravenous cytotoxic treatment are traditionally dispensed by supplying a convenient number of the manufacturer's original packs to obtain the doses required. Often these packs do not contain the exact dose, and in most cases the drug is presented as a sterile freeze-dried powder requiring reconstitution. The task of reconstituting and presenting the required dose has largely been abandoned by the pharmacist and left to the junior doctor or sometimes the nurse.
Only in the past few years have a few pharmacists started to consider the requirements for safe handling and suitable methods of dispensing intravenous cytotoxic drugs.'-7 We attempt to describe the requirements, how they were achieved in practice by developing a pharmacy-based intravenous cytotoxic drug dispensing service, and discuss some proposals for future developments.
Problems of reconstitution
The task of reconstitution is time-consuming and has several asso- With an extra member of staff intravenous cytotoxic prescriptions could be dispensed for outpatients as well as inpatients, and it is the outpatients that largely represent the increased work load since September 1980. In the immediate future we intend to look at the practicality of storing syringe-loaded drugs in a deep freeze (at -20°C) and using rapid thawing (perhaps using a microwave oven) when they need to be dispensed.
Advantages of a pharmacy-based intravenous cytotoxic drug service
There are several advantages of this service.
(1) Intravenous cytotoxic agents are reconstituted and dispensed under laminar flow conditions in a cabinet that provides protection for the operator as well as for the product.
(2) Intravenous cytotoxic agents are reconstituted and dispensed by highly trained pharmacy staff, who are aware of the hazards associated with handling these agents.
(3) Because of 1 and 2, handling of these agents on the wards is considerably reduced, as dry powders are rarely dispensed. The pharmacy service is currently reconstituting 98%o of all intravenous cytotoxic agents prescribed.
(4) Dispensing preloaded syringes has three main advantages: (a) Minimum handling by the doctor is required before these agents can be administered to the patient.
(b) The risk of accidental overdosage is eliminated as the exact patient dose is dispensed.
(c) Much money previously wasted may be saved. the pharmacy has assumed responsibility for the dispensing and presentation of these agents. Questionnaires issued to all house officers using the service asked them to indicate whether they considered the service to be (a) essential, (b) useful, or (c) superfluous. All replies indicated that the user considered the service to be essential. (6) Since the appointment of a full-time basic grade pharmacist few reconstituted cytotoxics are wasted. Returned syringes are reused whenever possible, and several patient doses can be removed from one vial. It is estimated that £5000 (from a total bill of £47 500 a year for intravenous cytotoxics) is being saved due to the more efficient method of dispensing. 
J H WINTER, J S LEGGE
Patients who receive immunosuppressive drugs for nonmalignant disorders develop mycobacterial infections more often than untreated individuals.' Active pulmonary tuberculosis has been found in patients with systemic lupus erythematosus (SLE) who are treated with high doses of corticosteroids.' We report on a patient with SLE who was receiving immunosuppressive treatment and presented with an acute tuberculous cervical lymphadenitis.
Case report
A 53-year-old woman was admitted with a two-day history of swelling in the left side of the neck and a one-day history of pain on swallowing. SLE had been diagnosed in 1960 and had mainly affected the skin and to a lesser extent the joints. She had been receiving prednisolone 15 mg daily and azathioprine 100 mg daily for several years with no problem. She was a smoker and had mild shortness of breath on exertion; there was no history of cough, sputum, night sweats, weight loss, or contact with tuberculosis.
The physical examination showed a large, erythematous exquisitely tender swelling of the left side of the neck, and vitiligo secondary to skin destruction related to SLE over the face (figure). Her temperature was 38°C and pulse rate 80 per min. Examination of the chest was normal. The results of investigations showed haemoglobin 113 g/dl; white cell count 5-7 x 109/1 (5700/mm3), with a differential count of neutrophils 82%, lymphocytes 14%, and monocytes 4%; platelet count 233 x 109/1 (233 000/mm3). Many acid-fast bacilli were seen in a sample of fluid aspirated from the swelling in the neck. Mycobacterium tuberculosis was cultured from this specimen and was 
